XSHE300132
Market cap338mUSD
Jan 02, Last price
4.96CNY
1D
0.61%
1Q
6.67%
Jan 2017
-52.66%
IPO
-49.12%
Name
Fujian Green Pine Co Ltd
Chart & Performance
Profile
Fujian Green Pine Co., Ltd. engages in the research, development, production, and sale of turpentine derivatives. The company offers synthetic camphor, isobornyl acetate, camphene, borneol flakes, para cymene, pinene, dipentene, isoborneol, crystalline sodium acetate, anhydrous sodium acetate, isobornyl (meth) acrylate, myrcene, benzyl acetate, QS keton, and solvent oils for applications in flavors, fragrances, pharmaceutical and personal care products, cleaning supplies, painting and coating fields, etc. It has operations in Asia, Europe, North America, South America, Oceania, and Africa. The company was formerly known as Jianyang City Green Pine Chemical Co., Ltd. and changed its name to Fujian Green Pine Co., Ltd. in May 2009. Fujian Green Pine Co., Ltd. was founded in 1958 and is headquartered in Jianyang, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 1,969,495 -32.49% | 2,917,366 -21.01% | |||||||
Cost of revenue | 1,867,404 | 2,969,032 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 102,090 | (51,666) | |||||||
NOPBT Margin | 5.18% | ||||||||
Operating Taxes | (18,769) | ||||||||
Tax Rate | |||||||||
NOPAT | 120,859 | (51,666) | |||||||
Net income | (68,341) | ||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
Debt | |||||||||
Debt current | 35,004 | 545,960 | |||||||
Long-term debt | 486,938 | 704,944 | |||||||
Deferred revenue | 28,070 | 21,706 | |||||||
Other long-term liabilities | 1,023 | ||||||||
Net debt | (172,986) | 524,654 | |||||||
Cash flow | |||||||||
Cash from operating activities | 156,605 | 340,637 | |||||||
CAPEX | (40,881) | ||||||||
Cash from investing activities | 384,586 | 40,690 | |||||||
Cash from financing activities | (476,434) | ||||||||
FCF | 799,548 | 725,392 | |||||||
Balance | |||||||||
Cash | 685,584 | 715,215 | |||||||
Long term investments | 9,344 | 11,035 | |||||||
Excess cash | 596,453 | 580,382 | |||||||
Stockholders' equity | 151,065 | 645,117 | |||||||
Invested Capital | 1,622,846 | 1,931,124 | |||||||
ROIC | 6.80% | ||||||||
ROCE | 5.64% | ||||||||
EV | |||||||||
Common stock shares outstanding | 516,581 | 516,581 | |||||||
Price | 5.22 -25.11% | 6.97 -38.26% | |||||||
Market cap | 2,696,552 -25.11% | 3,600,569 -38.26% | |||||||
EV | 2,526,996 | 4,127,282 | |||||||
EBITDA | 235,513 | 114,946 | |||||||
EV/EBITDA | 10.73 | 35.91 | |||||||
Interest | 25,063 | 61,390 | |||||||
Interest/NOPBT | 24.55% |